Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Assessment of quality of life as a tool for measuring morbidity due to Schistosoma mansoni infection and the impact of treatment.

Won KY, Abudho B, Blackstock AJ, Montgomery SP, Kennedy ED, Person B, Mwinzi PN, Ochola EA, Foo KT, Hightower AW, Karanja DM, Secor WE.

Am J Trop Med Hyg. 2014 Feb;90(2):322-8. doi: 10.4269/ajtmh.13-0361. Epub 2013 Dec 9.

2.

Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.

Garba A, Lamine MS, Barkiré N, Djibo A, Sofo B, Gouvras AN, Labbo R, Sebangou H, Webster JP, Fenwick A, Utzinger J.

Acta Trop. 2013 Nov;128(2):334-44. doi: 10.1016/j.actatropica.2012.08.008. Epub 2012 Aug 23.

PMID:
22940014
3.

Morbidity indicators of Schistosoma mansoni: relationship between infection and anemia in Ugandan schoolchildren before and after praziquantel and albendazole chemotherapy.

Koukounari A, Fenwick A, Whawell S, Kabatereine NB, Kazibwe F, Tukahebwa EM, Stothard JR, Donnelly CA, Webster JP.

Am J Trop Med Hyg. 2006 Aug;75(2):278-86.

PMID:
16896133
4.

Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.

Webster BL, Diaw OT, Seye MM, Faye DS, Stothard JR, Sousa-Figueiredo JC, Rollinson D.

Acta Trop. 2013 Nov;128(2):292-302. doi: 10.1016/j.actatropica.2012.09.010. Epub 2012 Sep 26.

PMID:
23022016
5.

Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.

Gryseels B, Stelma FF, Talla I, van Dam GJ, Polman K, Sow S, Diaw M, Sturrock RF, Doehring-Schwerdtfeger E, Kardorff R, et al.

Trop Geogr Med. 1994;46(4 Spec No):209-19.

PMID:
7825223
6.

Factors related to transmission of and infection with Schistosoma mansoni in a village in the South-eastern Region of Brazil.

Enk MJ, Lima AC, Barros Hda S, Massara CL, Coelho PM, Schall VT.

Mem Inst Oswaldo Cruz. 2010 Jul;105(4):570-7.

7.

Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda.

Tukahebwa EM, Vennervald BJ, Nuwaha F, Kabatereine NB, Magnussen P.

Trans R Soc Trop Med Hyg. 2013 Jun;107(6):397-404. doi: 10.1093/trstmh/trt024. Epub 2013 Apr 17.

PMID:
23596262
8.

Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.

Garba A, Lamine MS, Djibo A, Tahirou A, Aouami MA, Alfari A, Phillips AE, Fenwick A, Utzinger J.

Acta Trop. 2013 Nov;128(2):318-25. doi: 10.1016/j.actatropica.2012.12.003. Epub 2012 Dec 10.

PMID:
23237719
9.

Urban schistosomiasis: morbidity, sociodemographic characteristics and water contact patterns predictive of infection.

Firmo JO, Lima Costa MF, Guerra HL, Rocha RS.

Int J Epidemiol. 1996 Dec;25(6):1292-300.

PMID:
9027538
10.

Efficacy of praziquantel against Schistosoma mansoni in northern Senegal.

Picquet M, Vercruysse J, Shaw DJ, Diop M, Ly A.

Trans R Soc Trop Med Hyg. 1998 Jan-Feb;92(1):90-3.

PMID:
9692165
11.

Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.

Tchuem Tchuenté LA, Momo SC, Stothard JR, Rollinson D.

Acta Trop. 2013 Nov;128(2):275-83. doi: 10.1016/j.actatropica.2013.06.007. Epub 2013 Jun 20.

PMID:
23791803
12.

High level of Schistosoma mansoni infection in pre-school children in Sierra Leone highlights the need in targeting this age group for praziquantel treatment.

Hodges MH, Paye J, Koroma MM, Nyorkor ED, Fofonah I, Zhang Y.

Acta Trop. 2012 Nov;124(2):120-5. doi: 10.1016/j.actatropica.2012.07.005. Epub 2012 Jul 20.

PMID:
22820025
13.

High levels of Schistosoma mansoni infections among schoolchildren in central Sudan one year after treatment with praziquantel.

Ahmed AM, El Tash LA, Mohamed EY, Adam I.

J Helminthol. 2012 Jun;86(2):228-32. doi: 10.1017/S0022149X11000290. Epub 2011 Jun 8.

PMID:
21729382
14.

Sequential analysis of helminth egg output in human stool samples following albendazole and praziquantel administration.

Scherrer AU, Sjöberg MK, Allangba A, Traoré M, Lohourignon LK, Tschannen AB, N'Goran EK, Utzinger J.

Acta Trop. 2009 Mar;109(3):226-31. doi: 10.1016/j.actatropica.2008.11.015. Epub 2008 Nov 25.

PMID:
19070583
15.

Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia.

Berhe N, Gundersen SG, Abebe F, Birrie H, Medhin G, Gemetchu T.

Acta Trop. 1999 Jan 15;72(1):53-63.

PMID:
9924961
16.

Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity.

Butterworth AE, Sturrock RF, Ouma JH, Mbugua GG, Fulford AJ, Kariuki HC, Koech D.

Parasitology. 1991 Dec;103 Pt 3:339-55.

PMID:
1780171
17.

The impact of passive chemotherapy on Schistosoma mansoni prevalence and intensity of infection in the Egyptian Nile Delta.

El Sayed MK, Barakat R, Farghaly A, El Badway A, Soliman NK, Husein MH, Miller FD.

Am J Trop Med Hyg. 1997 Sep;57(3):266-71.

PMID:
9311634
18.

Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni.

Stelma FF, Talla I, Sow S, Kongs A, Niang M, Polman K, Deelder AM, Gryseels B.

Am J Trop Med Hyg. 1995 Aug;53(2):167-70.

PMID:
7677219
19.
20.

Metabonomic investigation of human Schistosoma mansoni infection.

Balog CI, Meissner A, Göraler S, Bladergroen MR, Vennervald BJ, Mayboroda OA, Deelder AM.

Mol Biosyst. 2011 May;7(5):1473-80. doi: 10.1039/c0mb00262c. Epub 2011 Feb 19.

PMID:
21336380

Supplemental Content

Support Center